A new approach to reducing the risk of pathogen contamination

JAX Reproductive Sciences is pleased to announce the implementation of an enhanced health monitoring system in room G200. The screening will now include an embryo wash test utilizing qPCR for detection of murine pathogens in embryos destined for implantation into pseudopregnant foster mothers. All of JAX standard practices to ensure the health status of animals in a maximum barrier remain in use.

Beginning May 15, 2015, these enhancements are reflected in the G200 Animal Health Report displaying embryo wash test results.

Webinar: "Aligning Health Surveillance and Risk in Embryo Transfer"

Watch our complimentary webinar presented by Robert Taft, Ph.D. and James Fahey, DVM on “Aligning Health Surveillance and Risk In Embryo Transfer”.

In this webinar you will learn more about our new proactive approach on health monitoring of the embryo transfer method, identifying risks associated with rederivation of imported mouse strains and risk mitigation through diagnostic testing.

Date: May 19, 2015

Time: 10am PT / 11am MT / 12pm CT / 1pm ET*

Important note: Webinar attendance is assured only for participants who register at least 1 hour prior to scheduled start time.

Dedication to maintaining the highest health status for JAX® Mice

The Jackson Laboratory has performed over 200,000 IVF/embryo transfer procedures in the past decade with a record of no contaminations of foster mothers or pups. JAX is the only mouse provider using a validated, fast and highly sensitive qPCR method of pathogen detection in embryos. This added testing measure underscores The Jackson Laboratory’s dedication to being proactive and maintaining the highest health status for JAX® Mice.

Mitigating health risks

To mitigate health risks in maximum barrier room G200, JAX is using a validated - more robust - health monitoring approach testing both the embryo washing fluid with sensitive q-PCR assays and a complete health assessment work-up of embryo-recipient females. The battery of tests to determine the health status of G200 includes the monitoring for viruses, bacteria (including helicobacter), mycoplasma, and parasites.

Leading the search for tomorrow's cures.